Denali Therapeutics Inc. - Common Stock (DNLI) stock analysis

DNLI · Denali Therapeutics Inc. - Common Stock

Latest recorded price: USD 18.08

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth -100.0%, ROIC -88.2%. The model flags 1 risk signal for this company (1 high severity).

Similar companies in Healthcare